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ABSTRACT
Acridine-4-carboxamides form a class of known
DNA mono-intercalating agents that exhibit cyto-
toxic activity against tumour cell lines due to their
ability to inhibit topoisomerases. Previous studies
of bis-acridine derivatives have yielded equivocal
results regarding the minimum length of linker
necessary between the two acridine chromophores
to allow bis-intercalation of duplex DNA. We report
here the 1.7 A˚ resolution X-ray crystal structure
of a six-carbon-linked bis(acridine-4-carboxamide)
ligand bound to d(CGTACG)2 molecules by non-
covalent duplex cross-linking. The asymmetric unit
consists of one DNA duplex containing an interca-
lated acridine-4-carboxamide chromophore at each
of the two CG steps. The other half of each ligand
is bound to another DNA molecule in a symmetry-
related manner, with the alkyl linker threading
through the minor grooves. The two crystallographi-
cally independent ligand molecules adopt distinct
side chain interactions, forming hydrogen bonds to
either O6 or N7 on the major groove face of guanine,
in contrast to the semi-disordered state of mono-
intercalators bound to the same DNA molecule. The
complex described here provides the first structural
evidence for the non-covalent cross-linking of DNA
by a small molecule ligand and suggests a possible
explanation for the inconsistent behaviour of six-
carbon linked bis-acridines in previous assays of
DNA bis-intercalation.
INTRODUCTION
Since the first evidence of naturally occurring antibiotics
binding to DNA by bis-intercalation (1), there have been
several studies aimed at the design of synthetic analogues
for therapeutic use. Bis-intercalation has the potential to
generate both kinetically and thermodynamically strong DNA
binding, leading to the inhibition of DNA replication, tran-
scription or topoisomerase activity. Antibiotics such as
echinomycin and the triostins, which exhibit anti-tumour as
well as anti-microbial activity, bind to DNA by inserting
two quinoxaline groups into the helical stack, with 2 bp
occluded between them (2,3). This finding is consistent
with the ‘neighbour exclusion principle’ first formulated to
describe mono-intercalator binding, which states that inter-
calation cannot occur at two consecutive base pair steps of
a DNA duplex. Much of the work on designing synthetic
analogues of these antibiotics has focused on bis-acridine
compounds, due to the stronger intercalative binding of the
acridine moiety compared with quinoxaline, and there have
been several efforts to determine the minimum linker
length between the two acridine groups necessary for bis-
intercalation. These studies have generally employed hydro-
dynamic techniques to detect unwinding of supercoiled
plasmid DNA or lengthening of linear DNA upon intercala-
tion by the ligand. Although compounds that have linkers
of seven or more atoms length have consistently been
shown to bis-intercalate (4–8), analogues with shorter linkers
have remained the subject of some controversy. Early experi-
ments gave conflicting results concerning whether linkers
of five or six atoms length allowed bis-intercalation (4,5),
leading to the suggestion that the nature of the linker
and any ring substituents may affect the length required (9).
At 7.5 and 8.8 A˚, respectively (assuming all-trans geometry),
five or six atom linkers are too short to allow bis-intercalation
without violating the neighbour exclusion principle. An NMR
study, whilst not resulting in a full structure determination,
indicated that a simple bis-acridine with a six carbon atom
linker bound mono-intercalatively (7), in contrast to the hydro-
dynamic data for the same compound (5). However, a recent
electrophoretic mobility assay suggested that compound 1
(Figure 1), a derivative with relatively potent antitumour
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activity, bis-intercalates in violation of the neighbour exclusion
principle (8).
The elucidation of the structures of triostin A and echino-
mycin bound to d(CGTACG)2 (2,3) has been followed by
other crystal structures of synthetic ligands bis-intercalating
palindromic DNA duplexes (10–13). However, such structures
are relatively elusive, partly due to the multiple chromophore
orientations which are accessible when long-flexible linkers
are used. In the naturally occurring antibiotics, which possess
cyclic linkers, there is a much smaller accessible conforma-
tional space and a structure which has evolved to have a
single DNA-binding mode. In contrast to the bis-intercalators,
many structures of mono-intercalating ligands bound to
DNA duplexes have been solved, including several of
acridine-4-carboxamides in complex with d(CGTACG)2
(14–17). Some members of this class of compounds are
known to have cytotoxic effects due to their ability to
inhibit topoisomerases (18). It has been suggested that bis-
intercalating derivatives of these, such as compound 1, the
subject of this work, could additionally act as transcription
inhibitors if they formed more long-lasting complexes than
their mono-intercalating equivalents (8). The only structure
of one of this series of bis-functional compounds bound to
DNA is that of the 8-carbon-linked analogue of 1 in complex
with d(CGTACG) (19). In those crystals, grown in the pres-
ence of Co2+ ions, the DNA did not exist as a simple duplex,
but instead formed a junction-like structure involving four
duplexes. Although the ligand linker was long enough to
allow classical bis-intercalation, the compound instead
bound to a novel quadruplex-like intercalation cavity formed
by exchange of bases between different duplexes in the junc-
tion. Several similar structures, all determined using crystals
grown in the presence of Co2+ ions, have been obtained with
mono-intercalators bound (20–24). Although the positive
charge of the bound ligands may be important in allowing
the juxtaposition of phosphate groups, this ability is clearly
not specific to bis-intercalators, and the Co2+ ions, identifiable
in the electron density maps, appear to play a crucial role in
stabilizing this structure.
A further mode of bis-intercalator binding, in which the
ligand cross-links two duplexes with one chromophore
incorporated into the base pair stack of each, has also been
suggested (25). Gel electrophoresis experiments using ligands
with rigid extended linkers, designed to promote cross-
linking over classical bis-intercalation, have provided circum-
stantial evidence for this mode of binding in the form of
knotted and catenated DNA (25,26). The authors of that
work noted, however, that formal proof of duplex cross-
linking would require structural characterization of the
ternary complex formed. Here, we provide the first such
structural evidence for a duplex cross-linking mode of
bis-intercalator binding, describing the X-ray crystal structure
of the six-carbon-linked bis(acridine-4-carboxamide) 1 bound
to d(CGTACG)2 molecules. The structure of the mono-
intercalator analogue of compound 1 bound to the same
DNA was solved previously by multi-wavelength anomalous
dispersion (MAD) using brominated derivatives of the ligand
and DNA (14,15). In that structure, the DNA crystallized with
a 2-fold axis relating the two strands within the duplex, and
two symmetry-related ligand molecules intercalating the CG
steps at each end. The ligand side chain occupied the major
groove of the DNA, with ND2 forming a hydrogen bond
with the G2 nucleotide, although the side chain was disor-
dered to a certain extent. In the structure presented here of
the bis-functional intercalator 1 in complex with the same
DNA, the individual chromophores bind in a manner similar
to the mono-intercalator, whilst the linker makes no direct
contacts with the DNA. Two crystallographically indepen-
dent acridine-4-carboxamide moieties are bound to the
duplex; in each case the other half of the ligand binds to
another duplex in a symmetry-related manner. The subtle dif-
ferences between the modes of binding of the two ligand
molecules in this structure and that of the monomer are
discussed, as are the implications of this structure on studies
of the effects of linker length.
MATERIALS AND METHODS
Synthesis of the six-carbon-linked bis(9-aminoacridine-
4-carboxamide)
The synthesis of compound 1 is outlined in Scheme 1 and
is similar to previously described methods (8,27). Commer-
cially available 2,2-iminodibenzoic acid was treated with
excess concentrated sulphuric acid to give 9(10H)acridone-
4-carboxylic acid, which was converted to 9-chloroacridine-
4-carbonyl chloride. The resulting unstable acid chloride
was immediately reacted with an excess of N,N-
dimethylethylenediamine in anhydrous dichloromethane buf-
fered with triethylamine and gave a good yield of the
9-chloroacridine-4-carboxamide with no concomitant replace-
ment of the nuclear chlorine. The synthesis was completed
by following a modified version of the procedure described
previously (8). The 9-chloroacridine-4-carboxamide was
dissolved in phenol and allowed to react with half a molar
(a)
(b)
Figure 1. Molecular formula (a) and atom numbering scheme (b) of 9,90-
(1,6-hexanediyldiimino)bis{N-[2-(dimethylamino)ethyl]}acridine-4-acarbox-
amide, referred to as compound 1 throughout the text and designated A4C in
the coordinate files. The numbering scheme is shown for only half of the
ligand due to internal symmetry. The two crystallographically independent
chromophores are referred to as DAC1 and DAC2, after the common
name for the N-[2-(dimethylamino)ethyl]acridine-4-carboxamide monomer,
DACA.
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equivalent of 1,6-diaminohexane. After heating at 55C for 24 h,
and suitable work up, compound 1 was purified using flash
column chromatography. The tetrahydrochloride salt of the
compound was prepared by treating the free base in MeOH
with 12 M HCl, followed by precipitation with EtOAc. The
salt was freeze-dried from water to give a yellow powder.
Crystallization and data collection
The self-complementary DNA oligonucleotide d(CGTACG)
was purchased from Eurogentec as a HPLC-purified solid.
Crystals containing the ligand 1 were grown by vapour dif-
fusion from sitting drops at 291 K. The drop contained 4 mL
10% (v/v) 2-methyl-2,4-pentanediol (MPD), 40 mM sodium
cacodylate, pH 7.0, 12 mM spermine, 80 mM SrCl2; 1 mL
1 mM DNA duplex and 1 mL of 375 mM 1. The drop
was equilibrated against a 1 mL reservoir of 35% (v/v)
MPD. Yellow crystals of octahedral shape and approximate
dimensions 0.2 mm · 0.1 mm · 0.1 mm appeared after 1
week. Initial screening and crystal indexing were carried out
at EMBL Hamburg beam line X13 and final data collection
was performed at the ESRF BM14. The structure was solved
by SAD at the Sr2+ K-edge absorption peak, in a modifica-
tion to a Sr2+ MAD procedure to be described in detail else-
where. X-ray diffraction data were collected at 100 K using
radiation of wavelength 0.769 s and a Mar Research CCD
detector. Data reduction and processing were performed
using the programs Denzo and Scalepack (28) (Table 1).
Structure solution and refinement
The structure was solved using the SHELXC/D/E programs
(29,30), as integrated in the HKL2MAP routines (31). The
space group of the crystal was determined as P4322 (with
a correlation coefficient of 71.43%, compared with 54.25%
for P4122) with two Sr
2+ ions located in the asymmetric
unit, one at half occupancy due to its location on an axis of
2-fold rotational symmetry. The initial model was obtained
from the previously determined structure of 6-bromo-9-
amino-DACA bound to d(CG5-BrUACG)2 (14) (NDB code
DDF073). Refinement was performed using SHELXL (32)
and model rebuilding carried out using Xtalview (33). Five
per cent of the reflections were selected randomly to monitor
the validity of the refinement and model rebuilding process
using the Rfree factor (34) (Table 1). The final coordinates
have been deposited in the NDB (35) (code DD0078) and
PDB (36,37) (code 2GB9), and structure factors are available
from the PDB. Full conformational analysis of the DNA is
available via the NDB, whilst a summary of the deviations
from the B-form conformation is provided below. Figures 2a
and 4–7 were produced using Molscript (38) and Raster3D (39).
RESULTS
Crystal packing and overall structure description
The complex of 1 bound to d(CGTACG)2 crystallized in the
space group P4322 in the presence of Sr
2+ ions, in a packing
which has not previously been observed for this DNA mole-
cule or any complex involving DNA-intercalating ligands.
The novel packing is due to the non-covalent cross-linking
of DNA duplexes by the bis-intercalator (Figure 2). The over-
all conformation of an individual duplex shows a strong
similarity to that already observed for the mono-intercalator
(14), allowing the model built de novo for that work to be
placed unchanged in the SAD electron density map as a start-
ing model for this structure, despite the significant differences
in packing. The asymmetric unit contains two d(CGTACG)
strands (designated A and B) that interact through Watson–
Crick base pairing to form a single duplex. This is in contrast
to the structures of the same DNA molecule with bound
mono-intercalators, in which a crystallographic axis of 2-
fold rotational symmetry relates the two strands within a
duplex. The electron-density maps (Figure 3) allowed the
Scheme 1. Synthesis of 1: (i) Conc. H2SO4, 100
C, 3 h, 99% yield.
(ii) (a) SOCl2, DMF (two drops), reflux, 30 min, 85% yield; (b) N,
N-dimethylethylenediamine, CH2Cl2, 0
C, 2 h, 67% yield. (iii) (a) Phenol,
120C, 1 h; (b) 1,6-diaminohexane, phenol, 55C, 24 h, 46% yield.
Table 1. X-ray data and refinement statistics
X-ray data
Unit cell dimensions, A˚ (P4322 spacegroup)
a (A˚) 37.46
b (A˚) 37.46
c (A˚) 53.55
a, b, g (degrees) 90.00
Resolution (A˚) (outer shell) 37.2–1.7 (1.79–71.70)
Unique reflections 4509 (626)
Anomalous multiplicitya 15.4 (15.3)
Anomalous completeness (%) 100.0 (100.0)
< I/s(I) > 4.2 (3.4)
Rmerge
b 6.4% (20.4%)
Refinement and model correlation
Resolution range (A˚) 8.0–1.7
No. of reflections used in refinement 4204
R-factorc 21.2%
No. of reflections used for Rfree 221
Rfree
c 25.5%
No. of DNA atoms 240
No. of ligand atoms 52
No. of water molecules 103
Average B-factors (A˚2)
DNA 19.1
Ligands 18.7
Water molecules 35.9
R.m.s. deviations from ideal geometry (targets in parentheses)
Bond lengths (A˚) 0.026
1,3 Distances defining angles (A˚) 0.021
aThe average number of observations of the same reflection.
bThe value of the merging R-factor between equivalent measurements of
the same reflection, RI ¼ SjI <I>j/SI.
cCrystallographic R-factor (Rfree) ¼ SkFoj  jFck/SjFoj.
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complete modelling of two acridine-4-carboxamide chro-
mophores in the asymmetric unit, as well as the DNA duplex
(except the 50 phosphate group of each strand), 103 water
molecules and one and a half Sr2+ ions, the anomalous signal
from which was used to obtain the SAD maps. The two
acridine-4-carboxamide moieties intercalate into the DNA
at the two distinct CG steps of the duplex. In each case, the
linker of the intercalator extends away from the duplex and
meets an axis of 2-fold rotational symmetry; thus, the
whole ligand is made up of two symmetry-related halves.
The bis-intercalators themselves mediate crystal packing by
cross-linking DNA molecules. Additionally, direct stacking
occurs between base pairs at opposite ends of symmetry-
related duplexes, without the involvement of a ‘spacer’
compound as seen in structures of this DNA molecule in
the presence of mono-intercalators (14–17). Cross-linking
occurs where these stacks pack against each other, with the
helix axes approximately orthogonal, although the two
ligand-binding sites are not equivalent in terms of crystal
packing. The close juxtaposition of duplexes linked through
their minor grooves allows direct hydrogen bonding interac-
tion between the phosphate group of G2(A) and the N2 group
of G6(B) of a symmetry-related helix.
Strontium ion interactions
Sr1 is situated in the minor groove of the DNA, at a pseudo-
symmetric position at the central TA step, and is therefore
remote from the ligand binding sites (Figure 4). The electron
density maps allowed the identification of six water mole-
cules coordinating Sr1. Previous studies of Sr2+ binding to
the DNA Holliday junction (40) have shown the ion to coord-
inate up to eight water molecules, so the hydration sphere
observed here is incomplete. The irregular arrangement of
the observed water molecules around this ion supports the
expectation that other, less ordered, water molecules are
also involved in its coordination. Two of the water molecules
coordinated to Sr1 form hydrogen bonds with the N3 groups
of A4(A) and A4(B), respectively, whilst a third interacts
with the phosphate group of a symmetry-related C5 nucleot-
ide. Sr2 is located on a crystallographic 2-fold axis and
four coordinating water molecules could be identified in the
electron density maps, consisting of two symmetry-related
pairs. As for Sr1, both the number and geometry of these
water molecules suggest that they do not form the complete
hydration shell for the ion. Sr2 does not lie in either groove
of the DNA duplex but is instead located between duplexes,
forming bridging interactions between the DNA backbones
(a)
(b)
Figure 2. (a) Ball-and-stick representation of DNA duplex cross-linking by
compound 1 in the crystal. The asymmetric unit contains a single duplex with
two mono-intercalated ligands. Each molecule of compound 1 lies on an axis
of 2-fold symmetry, with the other chromophore bound to a symmetry-related
duplex. The DNA molecule of focus is shown in green whilst symmetry-
related molecules are shown in yellow. In each case, strand B is indicated by
darker shading than strand A. The ligand is shown in space filling format.
(b) Schematic representation of the DNA cross-linking depicted in (a). The
asymmetric unit is indicated by the shaded box and symmetry-related
nucleotides are labelled with an asterisk. The major and minor grooves of
the DNA are depicted as hollow and filled arrows, respectively. Alternative
stereo views of Figures 2a, 4, 5, 6b and 7 are provided as online
Supplementary Data.
Figure 3. Example of the final electron density map, contoured at 1 s-level.
The region shown corresponds to the intercalation site of the DAC1
chromophore, viewed from the major groove face to highlight the definition
of the electron density for the side chain, which is semi-disordered in the
mono-intercalator complex (15).
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that may be important to crystal packing. One pair of
symmetry-related water molecules coordinated to Sr2 form
hydrogen bonds with the phosphate groups of their corre-
sponding C5(A) nucleotides, whilst another pair each contact
the phosphate groups of C5(B) nucleotides. Thus, a total of
four symmetry-related duplexes are linked by Sr2 and its
primary hydration shell.
Conformation of the ligand and DNA/ligand
interactions
The two bound chromophores have very similar overall
orientations within the intercalation cavity, but differently
oriented side chains. The first chromophore (DAC1) interca-
lates at the C1G2(B)/C5G6(A) step of the DNA duplex,
with the ring that bears the side chain closest to strand B
(Figure 5a). The long axis of the acridine lies closest to
that of the G2(B)/C5(A) base pair, such that the intercalator
forms extensive p–p stacking interactions with the bases of
C5(A), G6(A) and G2(B), but less so with that of C1(B).
The side chain protrudes into the major groove of the
DNA duplex, adopting an extended conformation in the 30
direction of strand B. Thus, the protonated ND2 group lies
approximately in the plane of the G2(B) base, where
it forms a hydrogen bond with N7 at a distance of 2.8 s.
ND1 forms a water-mediated hydrogen bonding interaction
with the phosphate group of G2(B) identical to that observed
in previously determined structures of acridine-4-carboxamide
mono-intercalators bound to this DNA molecule. The CD1
atom of the side chain does not form a planar centre; it lies
in the plane of the acridine ring, whereas both OD1 and
ND1 are positioned on the same side of this plane as the
rest of the side chain. The carbonyl oxygen of the carboxam-
ide group, OD1, forms a hydrogen bond with N10 of the
acridine ring, demonstrating that N10 must be protonated
under the conditions in the crystal. The linker lies in the
minor groove and extends away from the DNA molecule,
surrounded by largely disordered solvent.
The second chromophore within the asymmetric unit
(DAC2) is situated at the C5G6(B)/C1G2(A) step (Figure 5b).
The conformation of this intercalator is similar to that of
the other, but with some subtle differences in the contacts it
forms with the DNA. The side chain lies in the major groove,
extending in the 30 direction along strand B of the DNA, and
the acridine ring is again positioned such that its long axis is
almost parallel to that of the base-pair nearest the side chain.
Thus the ligand forms extensive p–p stacking interactions with
the bases of C1(A), G2(A) and G6(B), but a less extensive
(a)
(b)
C5*
C5*
Figure 4. Interactions formed by the two Sr2+ ions in the asymmetric unit.
(a) Sr1 bound in the minor groove of the DNA duplex, at the central TA step.
(b) Sr2-mediating crystal packing contacts between the backbones of several
DNA strands. Sr2+ ions are shown in magenta and water molecules in orange.
Coordination bonds to the ion and hydrogen bonds (except those involved
in standard Watson–Crick base pairing) are represented by grey lines.
(a)
(b)
G6*
C5
Figure 5. DNA duplex cross-linking by DAC1 (a) and DAC2 (b). The
left-hand side of each ligand is shown in a similar orientation, to highlight
the similarities and differences in binding between the two independent
observations.
Nucleic Acids Research, 2006, Vol. 34, No. 22 6667
 at U
niversity of Reading on January 20, 2016
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
contact with the base of C5(B). The geometry at CD1 is again
non-planar, with the OD1 and ND1 groups on the same side of
the acridine plane as the rest of the side chain. The OD1 car-
bonyl group forms a hydrogen bond with N10 of the chro-
mophore, indicating protonation of the ring nitrogen. The
most significant difference between the interactions formed
by the two chromophores is the nature of the hydrogen bond
formed by the ND2 group of the side chain. In this case,
ND2 acts as a hydrogen bond donor to O6 of the G6(B)
base, at a distance of 2.7 s. ND1 forms hydrogen bonding
interactions with the phosphate groups of G6(B) and C5(B)
via one and two water molecules, respectively. The contact
with G6 is essentially the same as the conserved interaction
described above for DAC1 with G2. However, there is no
equivalent of the C5 interaction for DAC1, as the phosphate
group of C1 is disordered. The linker of DAC2 extends away
from the DNA through the minor groove, but the solvent is
more ordered here than in the vicinity of DAC1. Thus, a net-
work of water-mediated hydrogen bond interactions linking
N9 of the ligand to O40 of G2(B) and O2 of C1(B) is observed.
Conformation of the DNA
The two distinctive conformations of the ligand, with the side
chain forming a hydrogen bond with either the guanine O6
or N7 atoms, show both similarities and differences in their
effect upon the DNA around them (Figure 6). In strand B,
the opening of the CG steps to allow intercalation is achieved
through a series of subtle changes in backbone torsion angles
that are almost identical for the two binding sites. The b
angles of the two guanine nucleotides in this strand are
changed by an average of +38 and the e angle of G2 by
37 (there is no e angle for the terminal G6 nucleotide).
The z angles of all nucleotides in strand B are higher than
the average value for B-DNA. This is particularly the case
for the two cytosine nucleotides, where the change is +34.
Similarly, the d angles are lower than in B-DNA in all strand
B nucleotides except the two guanines. This effect is also
most pronounced in the cytosine nucleotides, at an average
change of 42. In contrast to the subtle conformational
changes in strand B, in strand A specific backbone torsion
angles are significantly perturbed from the values expected
for B-DNA, and these changes are different for the two ligand
binding sites. The a and g angles of G2 differ from those for
B-DNA by 114 and +131, respectively, whilst the same
angles in G6 are changed by +129 and 129 relative to
B-DNA. The z angles of strand A are generally higher than
expected, but the two cytosine nucleotides show very differ-
ent behaviour to each other. The largest change in z is +49 in
C1, whereas C5 shows a change of 27. Overall, the con-
formation of the DNA backbone at the two ligand-binding
sites is very similar in strand B, to which both side chains
bind, but significantly different in strand A. This is evidenced
by the fact that pairs of equivalent backbone torsion angles
at the intercalation sites differ by an average of only 6.3 in
strand B, but by 56.2 in strand A.
The DNA structure shows no major perturbations of
individual base pair geometry compared to native B-DNA,
and no apparent correlations between the binding sites of
the two ligands. The most notable feature in this regard is
that the C5(A)–G2(B) base pair is flattened with respect to
its propeller twist, a feature that is accompanied by a slightly
higher buckle than that of the other base pairs. The base pair
step parameters, however, show more notable deviations from
previously observed norms. As expected, the intercalation
sites for DAC1 and DAC2 have similar local rise values of
6.8 and 6.7 A˚, respectively, approximately twice the size of
the non-intercalated base pair steps. The only shift or slide
value > 0.5 A˚ is a slide (translation along base pair long axis)
of 0.75 A˚ at the intercalation site of DAC1. The intercalation
site of DAC2 shows the largest tilt and roll, at 5.2 and 11.0,
respectively. The twist angles at the two intercalation sites,
(a)
(b)
Figure 6. Conformational analysis of the DNA. (a) Definition of DNA
backbone torsion angles, using the A4(A) nucleotide (which adopts a
conformation close to B-form DNA) as an example. For clarity, the ribose
rings and bases are shown only as outlines. (b) Superposition of the DAC1
(green), DAC2 (yellow) and 9-amino-DACA mono-intercalator (14) (grey)
binding sites.
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when defined relative to the helix axis, are in very close agree-
ment with each other at 22.6 and 22.4. However, these angles
are 21.9 and 18.8 for DAC1 and DAC2, respectively, when
defined locally. The helical twist angles for the non-intercalated
steps, in the 50 to 30 direction along strand B, are 25.0, 37.0 and
31.9, with the locally defined angles very similar.
DISCUSSION
The structure presented here represents the first crystallo-
graphic evidence of a small molecule ligand non-covalently
cross-linking two DNA duplexes. There are two crystallo-
graphically independent observations of this phenomenon
in the structure, and comparison of the two with each other,
and with complexes of related mono-intercalators, can yield
valuable information on the general principles of how these
classes of compounds bind to DNA. A notable feature of
this structure is that each half of the bis-intercalator binds
to the DNA in a fashion similar to that of the equivalent
mono-intercalator (Figure 6b). Intercalation is accompanied
by helix extension and unwinding, both of which have
been used to detect ligand binding in viscometric studies
(4–6,8,9). Indeed, compound 1 has previously been classified
as a bis-intercalator on the basis that it causes an unwinding
of 36 per ligand in plasmid DNA, approximately double that
of the monomer (8). The helix unwinding angle suggested by
this structure, taking account of the effects on adjacent base
pair steps, is 29 per chromophore. Classical bis-intercalation
by this ligand would require either violation of the neigh-
bour exclusion principle or significant bending of the DNA,
because the linker is too short to span 2 bp in an undistorted
duplex. The structure presented here raises the possibility
that a certain amount of DNA cross-linking during solution
studies may have complicated these experiments, accounting
for the inconsistencies in results regarding bis- versus mono-
intercalation for compound 1 and other ligands with similar
linker lengths (4–9). Here, we show directly that compound
1 can bind to DNA by duplex cross-linking, in the crystalline
state at least, whereas the solution data suggesting that 1 may
bis-intercalate result from indirect methods. It remains to be
determined whether other ligands of interest with six-atom
linkers also cross-link DNA, and what the minimum and
maximum linker lengths for this mode of binding are. A
consideration of the geometry of cross-linking in the crystal
suggests no reason why the same mode of binding should not
be adopted in solution; the precise arrangement of duplexes
seems more likely to be an effect of the ligand cross-linking
than a cause of it, especially because the same DNA mole-
cule, when mono-intercalated, forms crystals with very
different symmetry. The fact that crystals with identical
morphology and very similar unit cell dimensions (data not
shown) were grown in the presence of various different
metal ions shows that the structure presented here is not influ-
enced significantly by the Sr2+ ions used for obtaining phase
information. Furthermore, the hexameric DNA helices pack
end-to-end to form pseudo-infinite stacks in the crystal,
indicating that there would be no steric clashes if the two
cross-linked DNA molecules were longer. Although both
independent observations of cross-linking involve DNA heli-
ces that are at 90 to each other, this is not an exact
relationship forced by crystal symmetry. The precise spatial
arrangement of the two helices, and therefore the overall con-
formation of the ligand, differs between the two observations
(Figure 5). In each case, the first three carbon atoms of the
linker extend away from the helix in a similar fashion,
through the minor groove (Figure 6b). The major conforma-
tional difference between the two linkers is found at the cen-
tral carbon–carbon bond, where DAC1 exhibits a gauche
torsion angle and DAC2 adopts a trans geometry. This, cou-
pled with less dramatic differences in the two torsion angles
either side (which are identical to each other due to symme-
try), results in the linkers of the two ligands each bending
90, in almost opposite directions. Hence, the flexible nature
of the linker allows the ligand to cross-link duplexes in an
adaptable manner, despite previous suggestions that linker
rigidity may promote a cross-linking mode of binding (25,26).
A striking feature of this structure is that the side chains
of the two ligand molecules extend in the same direction
along the helix, whereas in all of the mono-intercalator com-
plexes the side chains of the two symmetry-related bound
ligands have both pointed towards the centre of the hexanu-
cleotide. In the crystal, the DNA helices pack together to
form pseudo-infinite stacks, and ligand cross-linking occurs
between duplex molecules in neighbouring stacks. Unlike
in the structures containing mono-intercalators, there is no
‘spacer’ ligand molecule stacked between the duplexes, so
the extended DNA stacks in the crystal resemble longer
DNA except for the breaks in the backbones every 6 bp.
The fact that the side chain of DAC2 interacts with G6(B)
sterically prevents that of DAC1 interacting with G6(A),
because these two guanines are part of adjacent base pairs
in the pseudo-infinite stack (Figure 7). The DAC1 chro-
mophore therefore intercalates in the correct orientation for
its side chain to form a hydrogen bond with G2(B). Hence
the side chains of both ligands contact guanines in strand B
rather than strand A. Bearing in mind that the two ends of
each hexameric DNA duplex are not equivalent in terms of
their packing with molecules in other helical stacks, it is
unclear whether a different crystal of the same morphology
and packing could contain ligand chromophores that are all
rotated by 180 relative to the situation here, with their side
chains all extending in the opposite direction along the minor
groove and all forming hydrogen bonds with guanines in
strand A. There is also no steric reason why, even in the
absence of intra-duplex crystallographic symmetry, the two
ligands bound to each hexamer should not have their side
chains both extending towards the centre of the duplex, as
in the structure with bound monomer. Alternatively, the crys-
tal could even contain a mixture of alternative side chain
orientations, as long as the two ligands at neighbouring
ends of adjacent molecules within a stack adopt the same
side chain direction as each other. Hence, the orientations
adopted here can be taken to represent a genuine preference
of the ligand under these crystalline conditions.
Previous structural work involving the mono-intercalating
equivalent of compound 1 has shown that the protonation
state of N10 has a significant effect on side chain geometry
(14). In the present structure, both ligands are protonated
at this site, and therefore have the side chain oriented with
the carboxamide oxygen close enough to N10 to act as the
acceptor in an intramolecular hydrogen bond. This contrasts
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with the conformation observed if N10 is not protonated, in
which the side chain is rotated by 180 so that the carbox-
amide nitrogen acts as the donor in a hydrogen bond with
N10. Despite the two ligands adopting the same geometry
at the carboxamide group, they differ in terms of the hydro-
gen bond contacts that the side chains make in the major
groove of the DNA. In DAC1, the ammonium group of the
side chain forms a hydrogen bond with N7 of G2(B), in a
manner identical to the major conformation of the monomer
(14). The side chain of DAC2, however, forms a hydrogen
bond with O6 of G6(B). It has been noted before for the
monomer that the dimethylaminoethyl section of the side
chain is partially disordered, and that refinement of a single
conformation can result in a position in which hydrogen
bond formation to both O6 and N7 is plausible (15). In the
complex with compound 1 presented here, the two indepen-
dent observations of the ligand show two distinct conforma-
tions, each of which is well-ordered. This suggests that the
disorder observed for the mono-intercalator results from a
combination of these two preferred alternative conformations.
The central conformation reported before (15), in which there
are two putative hydrogen bonds, appears to be an average of
the two positions observed here which, although it could
represent a transitional intermediate, is not necessarily highly
populated itself. The reasons behind the greater side chain
ordering in the bis-intercalator are not clear, but a possible
reason for the distinction between the two observations of
the ligand is the difference in electrostatic potential at the
two binding sites. At G2, the sugar-phosphate backbone is
contiguous, and therefore the positively charged side chain
is attracted towards the phosphate group as well as the partial
negative potential of the major groove face of the guanine
base. The side chain of DAC1 thus lies close to N7, and
forms a hydrogen bond there. In contrast, the lack of phos-
phate negative charge at the interduplex site 30 to G6
means that the side chain of DAC2 occupies a more central
position within the major groove and thus forms a hydrogen
bond with O6.
Strands A and B might be expected to show some distinc-
tive structural characteristics due to the fact that both ligand
side chains interact with strand B, making it the main focus
of phosphate charge neutralization by the compound. The
temperature factors for strand B are noticeably higher for
the AT base pairs than for the GC ones, but those for strand
A increase steadily from 50 to 30 (data not shown). This may
be because the guanines and cytosines of strand B receive a
stabilizing effect from hydrogen bond interactions with the
ligand side chains, whereas the only stabilizing hydrogen
bond for strand A is a crystal packing contact involving the
50 end of the DNA backbone. When comparing the effects
of ligand binding on various nucleotides in this structure
and those of the mono-intercalator complexes it is important
to distinguish between nucleotides that are co-ordinated by
ligand side chains and those that are not. The region C1–
G2 in the mono-intercalator complex is equivalent to
C1(B)–G2(B) and C5(B)–G6(B) in the sense of interacting
with the ligand side chain, and C5–G6 in the previous struc-
tures is equivalent to both C1(A)–G2(A) and C5(A)–G6(A).
Hence, it is possible to distinguish specific effects of the
intercalated ligand from more general position effects. The
coupled changes in the a and g torsion angles of G2 in the
mono-intercalator structure, which have been suggested to
be necessary for the opening up of the intercalation site, are
found in neither G2(B) nor G6(B), although they are found in
the non-equivalent G2(A). The different changes in a and g
associated with G6 in the mono-intercalator structure are
found only in G6(A) and not in G2(A) as expected, while in
the present structure a and g remain remarkably unchanged
from B-form DNA values in the G2(B) and G6(B) nucleo-
tides that are contacted by the ligand side chains. When
assessed in the same way, the previously identified decrease
in d (and associated switch to a C30-endo sugar pucker) for
the cytosine in the strand contacted by the ligand side chain
appears to be a consistent feature of intercalation. Changes in
z for both the cytosine and guanine in the side chain coordi-
nating strand also appear to be reasonably consistent.
SUMMARY
The structure presented here is the first showing a ligand non-
covalently cross-linking two DNA duplexes. Each half of the
symmetrical compound is based on known topoisomerase
inhibitors and binds in a way similar to those ligands, through
intercalation and hydrogen bond formation with the major
groove face of guanine. The structure suggests that linkers
Figure 7. The packing of the end of one DNA duplex with the opposite end of
a symmetry-related duplex to form a pseudo-infinite stack. The bound ligands
are shown in space filling format to illustrate that the side chain of DAC2
sterically prevents that of DAC1 from interacting with the terminal base pair
of the duplex to which it is bound. The symmetry-related chromophore of
each ligand has been omitted for clarity.
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of six-atoms (8.8 A˚) length may promote a cross-linking mode
of binding rather than bis-intercalation in violation of the neigh-
bour exclusion principle. Such non-covalent DNA cross-linking
could be of practical use in the study of inter-duplex contacts
during replication, transcription and topoisomerase activity.
The possible role of this mode of binding in the cytotoxicity
of the compound studied here requires further investigation.
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